Peter Maimonis
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
- Cancer Cells and Metastasis
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 10
- Radiopharmaceutical Chemistry and Applications 2
- Oncology 8
- HER2/EGFR in Cancer Research 4
- Cancer Treatment and Pharmacology 2
- Co-authors
- Steven H. Itzkowitz (1 shared paper)Shunji Ogata (1 shared paper)Wolfram Jäger (2 shared papers)Alexander Katalinic (2 shared papers)Tanja Fehm (2 shared papers)Donald Küfe (3 shared papers)Daniel F. Hayes (3 shared papers)Carl O’Hara (2 shared papers)
- Journals
- Blood (2 papers)Cancer (1 paper)Journal of Clinical Oncology (1 paper)Clinical Cancer Research (1 paper)Breast Cancer Research and Treatment (1 paper)
- Partner nations
- United StatesGermanyNetherlands
In The Last Decade
Peter Maimonis
19 papers receiving 586 citations
Peers
Comparison fields: 5 of 65
- Radiology, Nuclear Medicine and Imaging 252
- Oncology 294
- Immunology 159
- Cancer Research 77
- Molecular Biology 331
Countries citing papers authored by Peter Maimonis
This map shows the geographic impact of Peter Maimonis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Maimonis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Maimonis more than expected).
Fields of papers citing papers by Peter Maimonis
This network shows the impact of papers produced by Peter Maimonis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Maimonis. The network helps show where Peter Maimonis may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Maimonis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mucins bearing the cancer-associated sialosyl-Tn antigen mediate inhibition of natural killer cell cytotoxicity. | 1992 | 101 |
| 2 | 2001 | 89 | |
| 3 | Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen. | 1992 | 89 |
| 4 | 2000 | 70 | |
| 5 | 1997 | 60 | |
| 6 | 1997 | 51 | |
| 7 | 2016 | 37 | |
| 8 | 1981 | 21 | |
| 9 | A new radioimmunoassay detecting early stages of colon cancer: a comparison with CEA, AFP, and Ca 19-9. | 1992 | 18 |
| 10 | 2000 | 16 | |
| 11 | 1999 | 12 | |
| 12 | 2011 | 10 | |
| 13 | 1990 | 9 | |
| 14 | Detection and characterization of a high molecular weight human lung carcinoma-associated glycoprotein. | 1990 | 6 |
| 15 | 1999 | 4 | |
| 16 | Lung cancer-associated protein: development and characterization of a new assay that detects a circulating lung cancer marker. | 1991 | 3 |
| 17 | 2004 | 1 | |
| 18 | 2010 | 1 | |
| 19 | 1980 | 1 |
About Peter Maimonis
Peter Maimonis is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Immunology, Molecular Biology and Hematology, having authored 19 papers that have together received 599 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (10 papers), Glycosylation and Glycoproteins Research (6 papers), Galectins and Cancer Biology (4 papers), HER2/EGFR in Cancer Research (4 papers), Cancer Treatment and Pharmacology (2 papers), Ovarian cancer diagnosis and treatment (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (252 citations), Oncology (294 citations), Immunology (159 citations), Cancer Research (77 citations) and Molecular Biology (331 citations). Peter Maimonis has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include Steven H. Itzkowitz, Shunji Ogata, Wolfram Jäger, Alexander Katalinic, Tanja Fehm, Donald Küfe, Daniel F. Hayes, Carl O’Hara, Lucien Perey and Miyako Abe. Their work appears in journals such as Blood, Cancer, Journal of Clinical Oncology, Clinical Cancer Research and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.